Skip to content

The DEA May Permanently Change Internet Pharmacy Regulations

Internet pharmacy regulations may change due to DEAs newly proposed rules.

The global pandemic caused a worldwide shift toward telemedicine services, and with that societal change came a shift in internet pharmacy regulations. Read further to understand how the DEA’s new permanent rule changes can be traced back to their origin — an 18-year-old boy named Ryan Haight.

The Global Pandemic Caused a Historic Shift Toward Telemedicine — Altering Internet Pharmacy Regulations

This year, the Drug Enforcement Administration (DEA) proposed permanent rules surrounding the prescribing of controlled medications via telehealth appointments. "The proposed rules would provide safeguards for a narrow subset of telemedicine consultations — those telemedicine consultations by a medical practitioner that has: never conducted an in-person evaluation of a patient; AND that result in the prescribing of a controlled medication."

The DEA Proposes to Make Two Significant Changes

These permanent changes only apply to certain telemedicine consultations, and would enable providers to prescribe the following, without requiring a prior in-person examination:

  • a 30-day supply of Schedule III to Schedule V non-narcotic controlled medications
  • a 30-day supply of buprenorphine for the treatment of opioid use disorder

"DEA is committed to ensuring that all Americans can access needed medications," said DEA Administrator Anne Milgram in the statement. "The permanent expansion of telemedicine flexibilities would continue greater access to care for patients across the country, while ensuring the safety of patients. DEA is committed to the expansion of telemedicine with guardrails that prevent the online overprescribing of controlled medications that can cause harm." For now, the DEA, jointly with the Department of Health and Human Services (HHS), has extended current telemedicine flexibilities through December 31, 2024.

This All Began With the Ryan Haight Act in 2008

Ryan Haight was just 18 years old when he overdosed on Vicodin prescribed by a telehealth doctor who failed to conduct an adequate medical examination. The controlled substance was discreetly delivered to Haight by an online pharmacy. In 2008, Congress remembered Haight by passing the Ryan Haight Online Pharmacy Consumer Protection Act. In the years following, the use of telehealth services has continued to increase. This massive shift toward online care has incurred additional benefits, including cost savings and expanded access to healthcare. LegitScript predicted how a post-pandemic Ryan Haight Act may create uncertainty for telemedicine. Then, we considered how changes to the Ryan Haight Act could inspire a new era in telehealth — now that era is here.

Major Search Engines and Social Media Platforms Trust That LegitScript-certified Healthcare Providers Are Compliant With Internet Pharmacy Regulations

Are you a healthcare provider looking to advertise your telehealth services? LegitScript’s Healthcare Certification keeps the internet and payment ecosystems safer by thoroughly vetting providers seeking to advertise — assuring prospective patients you operate safely and legally.

Create an account to start your application today.

Smelting words into subject matter expertise since 2020, Thea Le Fevre specializes in B2B SaaS Content Marketing. She believes in embracing innovation and produces AI-assisted content along with organically crafted content. Take a deep dive into her work for up-to-date industry news surrounding issues in trust & safety, payments risk & compliance, healthcare, and more.

Recent Blog Articles

What’s Hiding on Your Marketplace? A Look at How Risk Infiltrates Your Platform

You monitor seller listings on your e-commerce marketplace, but do you know what's going on behind the scenes - or, rather, behind the screens? Illegal and brand-damaging activity isn't always easy to spot, and the risk only compounds as your platform scales. In this post, we explore violative activ...
Addiction Treatment Advisory Committee

Harnessing Collaboration: Highlights from LegitScript’s First Advisory Committee Meeting of the Year

Last year, LegitScript set out to relaunch its Addiction Treatment Certification Advisory Committee in order to strengthen avenues of communication and ensure the continued improvement of its Certification solutions. On March 27, 2024, the revitalized committee convened for the first time. Keep read...

Emerging Threat: Melanotan, Repackaging, and Online Sales

Despite continued regulatory action and potentially dangerous health effects, a social media trend promoting Melanotan II - an illicit tanning drug - continues to prevail in the market. LegitScript has observed that in an attempt to skirt account termination and regulatory scrutiny, merchants common...

Problematic Product Spotlight: Tianeptine

LegitScript has observed a recent rise in both the popularity and regulatory scrutiny of tianeptine, an unregulated substance commonly sold in gas stations and online - and often marketed with unproven claims to be a cognitive enhancer as well as an alternative to opioids. As such, manufacturers hav...